Company
Headquarters: Tokyo, Japan
Employees: 3,696
CEO: Mr. Taisuke Murai
¥64.05 Billion
JPY as of Jan. 1, 2026
US$408.7 Million
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $102.42 B |
| Cencora, Inc. | $65.71 B |
| Cardinal Health, Inc. | $48.88 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $9.44 B |
| Henry Schein, Inc. | $9.32 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc.; and medical and nursing care equipment. It also engages in the pharmacy and nursing care businesses; transportation business; insurance agent and real estate management businesses; parking business; mail-order business of health-related products; and pharmacy dispensing business. In addition, the company offers medical management consulting services; and manufactures OTC drugs. The company was founded in 2009 and is headquartered in Tokyo, Japan.
Vital KSK Holdings, Inc. has the following listings and related stock indices.
Stock: JPX: 3151 wb_incandescent
Stock: OTC: VKSKF wb_incandescent